Boldt J, Zickmann B, Benson M, Dapper F, Hempelmann G, Schindler E
Department of Anesthesiology and Intensive Care Medicine, Justus-Liebig-University Giessen, Germany.
Intensive Care Med. 1993;19(1):44-7. doi: 10.1007/BF01709277.
Platelet dysfunction secondary to cardiopulmonary bypass (CPB) is one of the major reasons for nonsurgical post-operative bleeding in cardiac surgery. Whether platelet size is an indicator for platelet function was investigated in patients undergoing coronary artery bypass grafting.
Prospective study.
Intra-operative, cardiac surgery operations.
80 consecutive patients undergoing coronary artery bypass grafting. Excluding criteria were pre-operative coagulation disorders and medication with anticoagulants within the last 10 days before the operation day.
Platelet function was assessed by aggregometry using a turbidimetric method (inductors: ADP 2.0 mumol/l, collagen 4 micrograms/l, epinephrine 25 mumol/l). Mean platelet volume (MPV) was measured by an electrical conductivity method. Measurements were carried out before, during, and after CPB until the 1st post-operative day on intensive care unit (ICU). Platelet size decreased significantly during CPB (max. -25% after weaning from bypass) and returned to baseline values on the 1st post-operative day. Platelet count (ranging from 93 - 304 x 10(9)/l) did not correlate significantly with MPV or aggregation variables. Maximum aggregation and maximum gradient of aggregation induced by ADP and collagen were significantly decreased by CPB with the most pronounced reduction at the end of CPB (ranging from -25% to -45%). Analyses of co-variance revealed a significant correlation between changes in MPV and changes in aggregation variables (ADP, collagen).
Platelet volume is easy to measure even in the operation room or in ICU and may indicate abnormalities in platelet function in the post-bypass period of cardiac surgery patients.
体外循环(CPB)继发的血小板功能障碍是心脏手术非手术性术后出血的主要原因之一。本研究在接受冠状动脉旁路移植术的患者中探讨血小板大小是否为血小板功能的一个指标。
前瞻性研究。
术中,心脏外科手术。
80例连续接受冠状动脉旁路移植术的患者。排除标准为术前凝血功能障碍以及手术日前10天内使用抗凝药物。
采用比浊法通过血小板聚集试验评估血小板功能(诱导剂:ADP 2.0 μmol/l、胶原4 μg/l、肾上腺素25 μmol/l)。采用电导率法测量平均血小板体积(MPV)。在CPB前、术中及术后直至重症监护病房(ICU)术后第1天进行测量。CPB期间血小板大小显著减小(脱离体外循环后最大减小25%),并在术后第1天恢复至基线值。血小板计数(范围为93 - 304×10⁹/l)与MPV或聚集变量无显著相关性。CPB使ADP和胶原诱导的最大聚集及最大聚集梯度显著降低,在CPB结束时降低最为明显(范围为-25%至-45%)。协方差分析显示MPV变化与聚集变量(ADP、胶原)变化之间存在显著相关性。
即使在手术室或ICU中血小板体积也易于测量,并且可能提示心脏手术患者体外循环后血小板功能异常。